KANSAS CITY, Mo. — The KC Animal Health Corridor is pleased to announce that Felixvet, an upcoming manufacturer of generic pharmaceuticals in the companion animal industry, selected Briarcliff, a northern suburb of Kansas City, Missouri, for its North American headquarters.
The company, based out of Ireland, decided to establish its presence in the KC region due to the strategic advantages of being situated within the Animal Health Corridor, the world’s largest concentration of animal health companies. The new office will serve as the center to support commercial and regulatory operations throughout the United States and Canada.
“We are confident that Felixvet is poised to become one of the leading companion animal generic drug companies globally,” said Vince Palasota, president of North America at Felix. “With our extensive pipeline, quick response capabilities and deep understanding of ANADA and brand competition strategies, we believe the veterinarian and marketing partners will recognize the significant value-added benefits we bring to the table.”
Neeraj Agrawal, CEO of Felix, stated, “We recently obtained FDA approval for India’s first oral solid dose facility dedicated to animal health pharmaceuticals and are nearing completion of our sterile fill injectable plant. Currently, Felixvet has been granted nine approvals for the United States market, with three additional products anticipated for approval by the end of 2023. These advancements give us a distinct competitive advantage in the animal health sector as we introduce our portfolio of products to the market.”
The KC region is located in the heart of the Animal Health Corridor, encompassing 56% of global animal health, diagnostics and pet food sales. Representing more than 300 animal health companies in the region, the KC Animal Health Corridor— an affiliate of the Kansas City Area Development Council — offers an unparalleled ecosystem for growth and collaboration.
“We are proud to welcome Felixvet, a business committed to advancing animal health through high-quality pharmaceuticals, to the Kansas City region,” said Kimberly Young, president of the KC Animal Health Corridor. “Here, Felix will enjoy proximity to many of their industry clients who call the KC Animal Health Corridor home, as well as abundant access to distribution resources and a robust animal health industry network.”
Founded in 2015 by Dr. Shumeet Banerji, Jon Symonds and Neeraj Agrawal, Felix is in the business of developing bio-equivalent generic pharmaceutical products for companion animals upon patent expiry. The company’s initial focus is to market and distribute these products in the U.S., upon approval by the Food and Drug Administration. Felix aims to be the first truly global generic companion animal pharmaceutical player focusing on the top 10 veterinary markets of the world. It aims to make bio-equivalent generics available at affordable prices from cGMP-compliant manufacturing plants.
About the KC Animal Health Corridor:
Representing more than half of the global animal health industry’s sales, and home to over 300 animal health companies, the KC Animal Health Corridor is the largest concentration of its kind worldwide. Anchored by Manhattan, Kansas, and Columbia, Missouri, the Corridor serves as a thriving hub for innovation and collaboration. For more information, please visit www.kcanimalhealth.com.
About the Kansas City Area Development Council (KCADC):
Serving the 18-county, two-state Kansas City area, the Kansas City Area Development Council is an economic development nonprofit that promotes the region’s business and lifestyle assets to companies and talent around the world. Working closely with its two states, and 50-plus county and community partners, the region has attracted more than 64,000 new jobs over its 45-year history. KCADC also leads the efforts behind the KC Animal Health Corridor, KC SmartPort, TeamKC, KC Heartland and KC Global Design. thinkKC.com
The post Felixvet Chooses Kansas City for North American HQ appeared first on Industry Today – Leader in Manufacturing & Industry News.